Gene · 2182
Papers4,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 4,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting GPX4 to Overcome Sorafenib Resistance of Human Hepatocellular Carcinoma by Inducing Ferroptosis. | J Cell Physiol | 2025 | 40763203 | PubTator, text mining | PubMed |
| Long non-coding RNA NORAD serves as a promoter of oncogenesis and inhibits ferroptosis via miR-144-3p-mTOR-ferritinophagy axis in cancer. | Eur J Med Res | 2025 | 40760677 | PubTator, text mining | PubMed |
| Andrographolide drives dual apoptosis and ferroptosis via caspase-3 and FACL4 in T-ALL cell lines. | Int J Hematol | 2025 | 40753138 | PubTator, text mining | PubMed |
| New insights into the dule roles CDK12 in human cancers: Mechanisms and interventions for cancer therapy. | J Pharm Anal | 2025 | 40747342 | PubTator, text mining | PubMed |
| Editorial: From bench to bedside: inflammation in neurovascular disorders and stroke. | Front Hum Neurosci | 2025 | 40746906 | PubTator, text mining | PubMed |
| New Insights into Potential Therapeutic Targets for Neuroendocrine Prostate Cancer: From Bench to Clinic. | Research (Wash D C) | 2025 | 40746825 | PubTator, text mining | PubMed |
| Single-cell sequencing-based study of ferroptosis mechanisms in heat stroke: identification of key biomarkers and dynamic analysis of the immune microenvironment. | BMC Med Genomics | 2025 | 40745616 | PubTator, text mining | PubMed |
| Vanillin restrains proliferation of triple negative breast cancer cells by inducing ferroptosis via mediating the KLF2/GPX4 axis. | Cytotechnology | 2025 | 40741604 | PubTator, text mining | PubMed |
| Comprehensive landscape of cell death mechanisms: from molecular cross-talk to therapeutic innovation in oncology. | Front Cell Dev Biol | 2025 | 40741332 | PubTator, text mining | PubMed |
| Effect of TP53 mutation, expression and polymorphism on the survival, immune infiltration and ferroptosis in patients with prostate cancer. | Oncol Lett | 2025 | 40740989 | PubTator, text mining | PubMed |
| Ferroptosis and bone health: bridging the gap between mechanisms and therapy. | Front Immunol | 2025 | 40740786 | PubTator, text mining | PubMed |
| Dimeric PKM2 induces ferroptosis from intestinal ischemia/reperfusion in mice by histone H4 lysine 12 lactylation-mediated HMGB1 transcription activation through the lactic acid/p300 axis. | Biochim Biophys Acta Mol Basis Dis | 2025 | 40738462 | PubTator, text mining | PubMed |
| TRIM21: a multifaceted regulator in cancer. | Front Cell Dev Biol | 2025 | 40735642 | PubTator, text mining | PubMed |
| Ferroptosis: a novel pharmacological mechanism against multiple myeloma. | Front Pharmacol | 2025 | 40735482 | PubTator, text mining | PubMed |
| Identification of differentially expressed genes associated with ferroptosis in ulcerative colitis. | PLoS One | 2025 | 40729322 | PubTator, text mining | PubMed |
| Different roles of ACSL3 and ACSL4 in autophagosome formation. | J Cell Sci | 2025 | 40728409 | PubTator, text mining | PubMed |
| Propofol is involved in neurotoxicity by mediating the occurrence of ferroptosis. | Medicine (Baltimore) | 2025 | 40725868 | PubTator, text mining | PubMed |
| Luteolin Inhibits Ferroptosis of HUVEC by Regulating the Sirt1/Nrf2 Pathway. | Cell Biochem Biophys | 2025 | 40721691 | PubTator, text mining | PubMed |
| The Combination of Celastrol and Curcumin Enhances the Antitumor Effect in Nasopharyngeal Carcinoma by Inducing Ferroptosis. | Biol Pharm Bull | 2025 | 40721368 | PubTator, text mining | PubMed |
| Promoting ferroptosis of keloid fibroblasts: a key mechanism underlying the efficacy of 5-aminolevulinic acid photodynamic therapy for keloids. | Photodiagnosis Photodyn Ther | 2025 | 40721067 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2182/papers?page=37